Immune thrombocytopenic purpura presenting as unprovoked gingival hemorrhage: A case report

Open Dentistry Journal

Volumn 8, Issue 1, 2014, Pages 164-167

  Bal, Mehmet V ^a   Koyuncuoglu, Cenker Z ^b   Saygun, Işıl ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ISTANBUL AYDIN UNIVERSITY   (Turkey)

Author keywords

Autoimmune disease; Dental care; Gingival hemorrhage; Haematologic diseases; Immune thrombocytopenic purpura; Platelet destruction

Indexed keywords

EID: 84928896278     PISSN: 18742106     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874210601408010164     Document Type: Article

References (29)

1. Long RG, Hlousek L, Doyle JL. Oral manifestations of systemic diseases. Mt Sinai J Med 1998; 65: 309-15.
2. Adeyemo TA, Adeyemo WL, Adediran A, et al. Orofacial manifestations of hematological disorders: anemia and hemostatic disorders. Indian J Dent Res 2011; 22: 454-61.
3. Stasi R, Newland AC. ITP: a historical perspective. Br J Haematol 2011; 153: 437-50.
4. Nieto M, Calvo G, Hudson I, et al. The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use. Haematologica 2011; 96: 33-40.
5. Harrington WJ, Minnich V, Hollingsworth JW, et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38: 1-10.
6. Harrington W, Arimura G, Minnich V. The autoimmune thrombocytopenias. Progress Hematol 1956; 1: 166-92.
7. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-86.
8. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-93.
9. Owais Z, Dane J, Cumming CG. Unprovoked periodontal hemorrhage, life-threatening anemia and idiopathic thrombocytopenia purpura: an unusual case report. Spec Care Dentist 2003; 23: 58-62.
10. Akin L, Herford AS, Cicciù M. Oral presentation of disseminated histoplasmosis: a case report and literature review. J Oral Maxillofac Surg 2011; 69: 535-41.
11. Yeager DA. Idiopathic thrombocytopenic purpura: report of case. J Am Dent Assoc 1975; 90: 640-3.
12. Ripamonti U, Petit JC, Penfold G, Lemmer J. Periodontal manifestations of acute autoimmune thrombocytopenic purpura: a case report. J Periodontol 1986; 57: 429-32.
13. Fenner M, Frankenberger R, Pressmar K, et al. Life-threatening thrombotic thrombocytopenic purpura associated with dental foci: report of two cases. J Clin Periodontol 2004; 31: 1019-23.
14. Sangwan A, Tewari S, Narula SC, et al. Significance of periodontal health in primary immune thrombocytopenia- a case report and review of literatüre. J Dent (Tehran) 2013; 10: 197-202.
15. Guzeldemir E. The role of oral hygiene in a patient with idiopathic thrombocytopenic purpura. Int J Dent Hyg 2009; 7: 289-93.
16. Vaisman B, Medina AC, Ramirez G. Dental treatment for children with chronic idiopathic thrombocytopaenic purpura: a report of two cases. Int J Paediatr Dent 2004; 14: 355-62.
17. Hata T, Hosoda M, Hamada Y, Kobayashi K. Steroid-induced damage to the condyles in treatment of idiopathic thrombocytopenia. Int J Oral Maxillofac Surg 2009; 38: 193-5.
18. Martini MZ, Lopez JS Jr, Gendler JL, et al. Idiopathic thrombocytopenic purpura presenting as post-extraction haemorrhage. J Contemp Dent Pract 2007; 8: 43-9.
19. Nakhoul IN, Kozuch P, Varma M. Management of adult idiopathic thrombocytopenic purpura. Clin Adv Hematol Oncol 2006; 4: 136-44.
20. Ahn YS, Horstman LL. Idiopathic thrombocytopenic purpura: pathophysiology and management. Int J Hematol 2002; 76, (Suppl 2): 123-31.
21. Peng J, Friese P, Heilmann E, et al. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood 1994; 83: 161-6.
22. Lacey JV, Penner JA. Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 1977; 3: 160-74.
23. Stasi R, Evangelista, ML, Stipa E, et al. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 2008; 99: 4-13.
24. Hunter ML, Hunter B, Lesser S. Acute idiopathic thrombocytopaenic purpura in childhood: report of a case presenting in general dental practice. Br Dent J 1997; 183: 27-9.
25. Ferrari A, Pasqualetti D, del Bianco P, et al. Prednisolone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications. Haematologica 1991; 76: 342-5.
26. Verbrunggen G, Herman L, Ackerman C, et al. The effect of low doses of prednisolone on T cell subsets in rheumatoid arthritis. Int Immunopharmacol 1987; 9: 61-7.
27. Stasi R, Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 2004; 79(4): 504-22.
28. Gupta A, Epstein JB, Cabay RJ. Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc 2007; 73: 77-83.
29. Finucane D, Fleming P, Smith O. Dentoalveolar trauma in a patient with chronic idiopathic thrombocitopenic purpura: a case report. Pediatr Dent 2004; 26: 352-4.